Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Pediatr Endocrinol Metab ; 31(6): 619-624, 2018 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-29750648

RESUMO

BACKGROUND: Congenital hypothyroidism (CH) is a common cause of mental retardation; it has a worldwide incidence ranging from 1:3000 to 1:4500 live births. Predictably, an increase in the reported incidence of primary CH occurs when the cut-off levels of thyroid-stimulating hormone are lowered. We aimed to evaluate the results of a congenital hypothyroidism screening program and current status in this study. METHODS: Analysis results of 1300 infants who were referred to the endocrinology polyclinic because of suspected CH within the scope of the Ministry of Health National Neonatal Screening Program were retrospectively evaluated. RESULTS: The diagnosis of CH and initiation of treatment were both done in 223 (18.5%) and 10 (0.8%) infants as a result of the initial evaluation and follow-up, respectively. The mean capillary and venous thyroid-stimulating hormone (TSH) levels of 223 patients were 40.78 (5.5-100) µIU/mL and 67.26 (10.7-100) µIU/mL, respectively. These patients' mean heel prick time was 8.65 (0-30, median: 7) days. The mean age of the 223 infants whose treatment was initiated as a result of the initial evaluation was 19.87 (4-51, median: 20) days, and the mean age of the infants whose treatment was started at follow-up was 43.71 (29-65) days. The duration between heel prick time and venous TSH time was 11.10 (2-28, median: 11) days and was longer than planned (3-5 days). CONCLUSIONS: Although the duration for the diagnosis and initiation of CH treatment were markedly reduced with the implementation of the screening program in Turkey compared to those before the implementation of the screening program, we have not yet achieved the ideal time (≤14 days).


Assuntos
Hipotireoidismo Congênito/diagnóstico , Triagem Neonatal , Hipotireoidismo Congênito/epidemiologia , Feminino , Humanos , Incidência , Recém-Nascido , Masculino , Programas Nacionais de Saúde , Triagem Neonatal/métodos , Triagem Neonatal/organização & administração , Triagem Neonatal/normas , Avaliação de Programas e Projetos de Saúde , Estudos Retrospectivos , Turquia/epidemiologia
2.
Pediatr Pulmonol ; 46(8): 820-3, 2011 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-21337729

RESUMO

Idiopathic pulmonary hemosiderosis (IPH) is a rare disease characterized by anemia, hemoptysis and recurrent alveolar hemorrhage. The combination of IPH and celiac disease (CD) is extremely rare. We report a 9-year-old boy with Lane-Hamilton syndrome, co-occurrence of pulmonary hemosiderosis with CD. This presentation is unique presentation because he has also retinal pigmentation.


Assuntos
Doença Celíaca/diagnóstico , Hemossiderose/diagnóstico , Pneumopatias/diagnóstico , Retinose Pigmentar/diagnóstico , Doença Celíaca/dietoterapia , Criança , Suplementos Nutricionais , Gliadina/efeitos adversos , Hemossiderose/dietoterapia , Humanos , Ferro/uso terapêutico , Pneumopatias/dietoterapia , Masculino , Retinose Pigmentar/dietoterapia , Hemossiderose Pulmonar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA